{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:54:51Z","timestamp":1773420891042,"version":"3.50.1"},"reference-count":64,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Science, Sports, and Culture of the Japanese Government","award":["22K09829"],"award-info":[{"award-number":["22K09829"]}]},{"name":"Eye Research Foundation for the Aged in Japan"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Non-arteritic ischemic optic neuropathy (NAION) results from vascular insufficiency within the optic nerve head. The precise pathogenesis of NAION remains unclear; however, insufficient blood supply from the short posterior ciliary arteries and the choroidal circulation has been associated with its development. Although major risk factors include diabetes, hypertension, and hyperlipidemia, coronavirus disease 2019 (COVID-19) may also contribute to the development of NAION. This literature review presents our case of NAION associated with COVID-19 infection and summarizes previously reported cases of NAION following COVID-19 infection published in the English-language literature worldwide. Because direct infection of ocular tissues, including ocular vessels, via the angiotensin-converting enzyme 2 receptor is thought to contribute to the development of NAION, cases of NAION associated with COVID-19 vaccination were excluded from this review. Furthermore, we discuss the possible molecular mechanisms underlying the development of NAION after COVID-19 infection and highlight the potential risks of COVID-19 for clinical ophthalmologists.<\/jats:p>","DOI":"10.3390\/ijms27062644","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:06:22Z","timestamp":1773414382000},"page":"2644","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenesis of Non-Arteritic Anterior Ischemic Optic Neuropathy Associated with COVID-19"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8273-845X","authenticated-orcid":false,"given":"Toshiyuki","family":"Oshitari","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan"},{"name":"Department of Ophthalmology, International University of Health and Welfare School of Medicine, 4-3 Kozunomori, Narita 286-8686, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00041327-200306000-00012","article-title":"Pathogenesis of nonarteritic anterior ischemic optic neuropathy","volume":"23","author":"Arnold","year":"2003","journal-title":"J. Neuroophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/WNO.0000000000000870","article-title":"Unraveling the Enigma of Nonarteritic Anterior Ischemic Optic Neuropathy","volume":"39","author":"Rizzo","year":"2019","journal-title":"J. Neuroophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00417-021-05522-4","article-title":"Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: A systematic review and meta-analysis","volume":"260","author":"Chatziralli","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08820538.2019.1620792","article-title":"Disc Configuration as a Risk and Prognostic Factor in NAION: The Impact of Cup to Disc Ratio, Disc Diameter, and Crowding Index","volume":"34","author":"Contreras","year":"2019","journal-title":"Semin. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"(1996). Ischemic Optic Neuropathy Decompression Trial Study Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch. Ophthalmol., 114, 1366\u20131374.","DOI":"10.1001\/archopht.1996.01100140566007"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bjophthalmol-2017-311140","article-title":"Prevalence and incidence of non-arteritic anterior ischaemic optic neuropathy in South Korea: A nationwide population-based study","volume":"102","author":"Lee","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref_7","first-page":"93","article-title":"The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis)","volume":"111","author":"Arnold","year":"2013","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)70902-X","article-title":"Nonarteritic anterior ischemic optic neuropathy: Time of onset of visual loss","volume":"124","author":"Hayreh","year":"1997","journal-title":"Am. J. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/archopht.1997.01100160112031","article-title":"Nonarteritic anterior ischemic optic neuropathy: Role of nocturnal arterial hypotension","volume":"115","author":"Hayreh","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/bjophthalmol-2018-312910","article-title":"Obstructive sleep apnoea and increased risk of non-arteritic anterior ischaemic optic neuropathy","volume":"103","author":"Yang","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ajo.2004.11.004","article-title":"Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure","volume":"139","author":"Behbehani","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0161-6420(94)31266-8","article-title":"Nonarteritic ischemic optic neuropathy. The impact of tobacco use","volume":"101","author":"Chung","year":"1994","journal-title":"Ophthalmology"},{"key":"ref_13","first-page":"e89656","article-title":"Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review","volume":"17","author":"Ramos","year":"2025","journal-title":"Cureus"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mitchell, R., and Chacko, J. (2022). Clinical and Mechanistic Review of Amiodarone-Associated Optic Neuropathy. Biomolecules, 12.","DOI":"10.3390\/biom12091298"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4103\/ijo.IJO_2365_21","article-title":"Bilateral sequential non-arteritic optic neuropathy post-COVID-19","volume":"70","author":"Sanoria","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Clarke, K.M., Riga, V., Shirodkar, A.L., and Meyer, J. (2021). Proning related bilateral anterior ischaemic optic neuropathy in a patient with COVID-19 related acute respiratory distress syndrome. BMC Ophthalmol., 21.","DOI":"10.1186\/s12886-021-02028-9"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/fvl-2021-0068","article-title":"Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: A case report","volume":"17","author":"Golabchi","year":"2022","journal-title":"Future Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e240542","DOI":"10.1136\/bcr-2020-240542","article-title":"Non-arteritic anterior ischaemic optic neuropathy sequential to SARS-CoV-2 virus pneumonia: Preventable by endothelial protection?","volume":"14","author":"Moschetta","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_19","first-page":"104","article-title":"Non-Arteritic Anterior Ischaemic Optic Neuropathy with Progressive Macular Ganglion Cell Atrophy due to COVID-19","volume":"46","year":"2021","journal-title":"Neuroophthalmology"},{"key":"ref_20","first-page":"e11950","article-title":"A Case of Non-Arteritic Anterior Ischemic Optic Neuropathy with COVID-19","volume":"12","author":"Rho","year":"2020","journal-title":"Cureus"},{"key":"ref_21","first-page":"e52158","article-title":"Non-arteritic Anterior Ischemic Optic Neuropathy Sequela From Potential COVID-19-Associated Coagulopathy","volume":"16","author":"Naber","year":"2024","journal-title":"Cureus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"NP133","DOI":"10.1177\/11206721221149762","article-title":"COVID-19 presenting as a non-arteritic anterior ischemic optic neuropathy","volume":"33","author":"Romozzi","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/cjn.2022.307","article-title":"Severe Anterior Ischemic Optic Neuropathy Due to COVID-19-Related Epistaxis","volume":"50","author":"Vosoughi","year":"2023","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_24","first-page":"143","article-title":"Bilateral Sequential Non-Arteritic Anterior Ischemic Optic Neuropathy Following COVID-19 Infection: A Rare Case Report","volume":"8","author":"Kiyat","year":"2023","journal-title":"Beyoglu Eye J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"101684","DOI":"10.1016\/j.ajoc.2022.101684","article-title":"Non-arteritic anterior ischemic optic neuropathy in COVID-19 infection\u2014A case report","volume":"27","author":"Sitaula","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1097\/WNO.0000000000001693","article-title":"Posterior Ischemic Optic Neuropathy Following Recurrent COVID-19 in Prior Bilateral Sequential Nonarteritic Anterior Ischemic Optic Neuropathy","volume":"44","author":"Chen","year":"2024","journal-title":"J. Neuroophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Shi, J., and Danesh-Meyer, H.V. (2024). A review of neuro-ophthalmic sequelae following COVID-19 infection and vaccination. Front. Cell Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1345683"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101857","DOI":"10.1016\/j.ajoc.2023.101857","article-title":"The spectrum of COVID-19-associated chorioretinal vasculopathy","volume":"31","author":"Carletti","year":"2023","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Liu, B., Yu, Y., Liu, W., Deng, T., and Xiang, D. (2021). Risk Factors for Non-arteritic Anterior Ischemic Optic Neuropathy: A Large Scale Meta-Analysis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.618353"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(07)60198-6","article-title":"The eye in hypertension","volume":"369","author":"Wong","year":"2007","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Savastano, A., Crincoli, E., Savastano, M.C., Younis, S., Gambini, G., De Vico, U., Cozzupoli, G.M., Culiersi, C., Rizzo, S., and Gemelli Against Covid-Post-Acute Care Study Group (2020). Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092895"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J. Virol."},{"key":"ref_37","first-page":"001","article-title":"Angiotensin Converting Enzyme 2 (ACE2) Expression in the Aged Brain and Visual System","volume":"9","author":"Hill","year":"2021","journal-title":"J. Aging Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.62.7.6","article-title":"Expression of the SARS-CoV-2 Receptor ACE2 in Human Retina and Diabetes-Implications for Retinopathy","volume":"62","author":"Zhou","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ahmad Mulyadi Lai, H.I., Chou, S.J., Chien, Y., Tsai, P.H., Chien, C.S., Hsu, C.C., Jheng, Y.C., Wang, M.L., Chiou, S.H., and Chou, Y.B. (2021). Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031320"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.stemcr.2022.02.015","article-title":"SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids","volume":"17","author":"Schreiber","year":"2022","journal-title":"Stem Cell Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.ajpath.2023.02.016","article-title":"Histopathology and SARS-CoV-2 Cellular Localization in Eye Tissues of COVID-19 Autopsies","volume":"193","author":"Sen","year":"2023","journal-title":"Am. J. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"578011","DOI":"10.1016\/j.jneuroim.2022.578011","article-title":"Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review","volume":"375","author":"Bosello","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"577939","DOI":"10.1016\/j.jneuroim.2022.577939","article-title":"Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review","volume":"371","author":"Feizi","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/ijo.IJO_2235_21","article-title":"COVID-19-associated optic neuritis\u2014A case series and review of literature","volume":"70","author":"Jossy","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bcp.12629","article-title":"Degradation of the endothelial glycocalyx in clinical settings: Searching for the sheddases","volume":"80","author":"Becker","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"568","DOI":"10.21037\/cdt.2018.07.01","article-title":"Interaction between platelets and endothelium: From pathophysiology to new therapeutic options","volume":"8","author":"Hamilos","year":"2018","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"Iba","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/HYPERTENSIONAHA.118.10266","article-title":"Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology","volume":"71","author":"Eguchi","year":"2018","journal-title":"Hypertension"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: The vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"The Ischemic Optic Neuropathy Decompression Trial Research Group (1995). Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA, 273, 625\u2013632.","DOI":"10.1001\/jama.1995.03520320035038"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ophtha.2007.05.027","article-title":"Nonarteritic anterior ischemic optic neuropathy: Natural history of visual outcome","volume":"115","author":"Hayreh","year":"2008","journal-title":"Ophthalmology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s00417-024-06512-y","article-title":"Evaluation and management of nonarteritic anterior ischemic optic neuropathy: A national survey","volume":"262","author":"Bialer","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9394(02)01639-2","article-title":"Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: Report from the ischemic optic neuropathy decompression trialfollow-up study","volume":"134","author":"Newman","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9394(14)70448-9","article-title":"The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy","volume":"121","author":"Botelho","year":"1996","journal-title":"Am. J. Ophthalmol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ophtha.2018.03.032","article-title":"Steroids versus No Steroids in Nonarteritic Anterior Ischemic Optic Neuropathy: A Randomized Controlled Trial","volume":"125","author":"Saxena","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e17861","DOI":"10.1097\/MD.0000000000017861","article-title":"Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: A PRISMA-compliant meta-analysis","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1055\/s-0040-1722270","article-title":"Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review","volume":"47","author":"Simion","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1056\/NEJMra1413352","article-title":"Ischemic Optic Neuropathies","volume":"372","author":"Biousse","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bjo.2010.191627","article-title":"Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy","volume":"95","author":"Modarres","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Parisi, V., Barbano, L., Di Renzo, A., Coppola, G., and Ziccardi, L. (2019). Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized pilot study. PLoS ONE, 14, Erratum in PLoS ONE 2019, 14, e0221313. https:\/\/doi.org\/10.1371\/journal.pone.0221313.","DOI":"10.1371\/journal.pone.0221313"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/WNO.0000000000000786","article-title":"Randomized Controlled Phase 2a Study of RPh201 in Previous Nonarteritic Anterior Ischemic Optic Neuropathy","volume":"39","author":"Rath","year":"2019","journal-title":"J. Neuroophthalmol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2644\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:07:13Z","timestamp":1773414433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27062644"],"URL":"https:\/\/doi.org\/10.3390\/ijms27062644","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}